{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:02:36Z","timestamp":1792699356868,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jocn.2020.04.076","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T07:47:17Z","timestamp":1587541637000},"page":"185-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Disability and quality of life in Guillain-Barr\u00e9 syndrome \u2013 Longitudinal study"],"prefix":"10.1016","volume":"78","author":[{"given":"Ivana","family":"Berisavac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Arsenijevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Bozovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branka","family":"Mladenovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Kacar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Stojiljkovic Tamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milutin","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Stojanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balsa","family":"Vujovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Martic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejana","family":"Jovanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Lavrnic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Basta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stojan","family":"Peric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2020.04.076_b0005","series-title":"Adams and victor's principles of neurology","author":"Ropper","year":"2005"},{"key":"10.1016\/j.jocn.2020.04.076_b0010","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2020.04.076_b0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2004.09.021","article-title":"Impairment in Guillain-Barr\u00e9 syndrome during the first 2 years after onset: a prospective study","volume":"227","author":"Forsberg","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2020.04.076_b0020","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1191\/0269215505cr918oa","article-title":"Disability and health-related quality of life in Guillain-Barr\u00e9 syndrome during the first 2 years after onset: a prospective study","volume":"19","author":"Forsberg","year":"2005","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.jocn.2020.04.076_b0025","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"Van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jocn.2020.04.076_b0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0404.2010.01366.x","article-title":"Clinico-electrophysiological findings and prognosis of Guillain-Barr\u00e9 syndrome\u201310 years' experience","volume":"123","author":"Soysal","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jocn.2020.04.076_b0035","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in Guillain-Barre syndrome","volume":"76","author":"Walgaard","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2020.04.076_b0040","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","article-title":"A clinical prognostic scoring system for Guillain-Barr\u00e9 syndrome","volume":"6","author":"Van Koningsveld","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2020.04.076_b0045","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp.62.6.637","article-title":"Residual health status after Guillain-Barr\u00e9 syndrome","volume":"62","author":"Bernsen","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2020.04.076_b0050","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJM199603283341306","article-title":"Assessment of quality-of-life outcomes","volume":"334","author":"Testa","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2020.04.076_b0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/jns5.12051","article-title":"Health-related quality of life in Guillain-Barr\u00e9 syndrome patients: a systematic review","volume":"19","author":"Darweesh","year":"2014","journal-title":"J Peripher NervSyst"},{"key":"10.1016\/j.jocn.2020.04.076_b0060","doi-asserted-by":"crossref","unstructured":"Merkies IS, Schmitz PI, van der Mech\u00e9 FG, Samijn JP, van Doorn PA; Inflammatory Neuropathy Cause and Treatment (INCAT) group. Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Neurology 2002;59:84\u201391. https:\/\/doi.org\/10.1212\/WNL.59.1.84.","DOI":"10.1212\/WNL.59.1.84"},{"key":"10.1016\/j.jocn.2020.04.076_b0065","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/ane.13195","article-title":"Six-month prospective study of quality of life in Guillain-Barre syndrome","volume":"141","author":"Djordjevic","year":"2020","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jocn.2020.04.076_b0070","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jocn.2020.04.076_b0075","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ncl.2013.01.005","article-title":"Guillain-Barr\u00e9 syndrome and variants","volume":"31","author":"Dimachkie","year":"2013","journal-title":"Neurol Clin"},{"key":"10.1016\/j.jocn.2020.04.076_b0080","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2020.04.076_b0085","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011595","article-title":"Pain during the acute phase of Guillain-Barr\u00e9 syndrome","volume":"97","author":"Yao","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jocn.2020.04.076_b0090","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1212\/WNL.48.2.328","article-title":"Pain in Guillain-Barr\u00e9 syndrome","volume":"48","author":"Moulin","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2020.04.076_b0095","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.0b013e3181f88345","article-title":"Pain in Guillain-Barre syndrome: a long-term follow-up study","volume":"75","author":"Ruts","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2020.04.076_b0100","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00415-009-0018-z","article-title":"Fatigue, pain and muscle weakness are frequent after Guillain-Barr\u00e9 syndrome and poliomyelitis","volume":"256","author":"Rekand","year":"2009","journal-title":"J Neurol."},{"key":"10.1016\/j.jocn.2020.04.076_b0105","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1017\/cjn.2018.12","article-title":"Three-year follow-up study in patients with Guillain-Barr\u00e9 syndrome","volume":"45","author":"Martic","year":"2018","journal-title":"Can J NeurolSci"},{"key":"10.1016\/j.jocn.2020.04.076_b0110","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1007\/s00415-010-5653-x","article-title":"Factors associated with long term functional outcome and psychological sequelae in Guillain Barre syndrome","volume":"257","author":"Khan","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2020.04.076_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.25112","article-title":"Neuropsychiatric manifestations in inflammatory neuropathies: a systematic review","volume":"54","author":"Rajabally","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2020.04.076_b0120","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/mus.21536","article-title":"Psychosocial dysfunction in the first year after Guillain-Barre syndrome","volume":"41","author":"Bernsen","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2020.04.076_b0125","doi-asserted-by":"crossref","first-page":"79991","DOI":"10.18632\/oncotarget.20620","article-title":"Long-term prognosis of Guillain-Barr\u00e9 syndrome not determined by treatment options?","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jocn.2020.04.076_b0130","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","article-title":"Campylobacter jejuni infection and Guillain-Barr\u00e9 syndrome","volume":"333","author":"Rees","year":"1995","journal-title":"N Engl J Med"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586820304343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586820304343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:27:24Z","timestamp":1760822844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586820304343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":26,"alternative-id":["S0967586820304343"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2020.04.076","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disability and quality of life in Guillain-Barr\u00e9 syndrome \u2013 Longitudinal study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2020.04.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}